Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - November 21, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/22/17 - Senate HELP Committee Receives Testimony From Joint HHS Witnesses on Opioids
The Senate Health, Education, Labor and Pensions Committee issued the following joint testimony by Elinore McCance-Katz, assistant secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration; Deborah Houry, director of the National Center for Injury Prevention and Control, Centers for Disease Control and
10/20/17 - Alvogen Obtains First Approval for Glatiramer Acetate 40 mg/mL in Europe
The company has commercial operations in 35 countries with 2,800 employees and operates four manufacturing and development hubs in the US, Romania, Korea and Taiwan. North America is Alvogen's single largest market and other key markets include: South Korea, Russia, Hungary, Romania, Taiwan, Ukraine, Japan and China. A consortium of investors, led
10/20/17 - Health Canada Grants Priority Review Status to trifluridine and tipiracil for Refractory Metastatic Colorectal Cancer
-Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd., today announced that Health Canada accepted for review Taiho's New Drug Submission for trifluridine and tipiracil, and that the NDS has been granted Priority Review status. If approved by Health Canada, FTD and TPI could become a new important treatment option for
10/20/17 - Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product
Innovus Pharmaceuticals Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced that it has received approval from Health Canada to market its best-selling, clinically...
10/20/17 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
10/19/17 - Antacids Market to Witness Exponential Growth by 2025: Transparency Market Research has announced the addition of the Antacids Market: Global Industry Analysis and Opportunity Assessment, 2017-2025"report to their offering.
Albany, NY 10/19/2017 With a large pool of established players such as AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson& Johnson, Pfizer Inc., Procter& Gamble, Reckitt Benckiser Group plc, Sanofi, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Ltd., and Valeant Pharmaceutic
10/19/17 - Aurobindo Pharma receives USFDA Approval for Esomeprazole Magnesium DR Capsules OTC
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food& Drug Administration to manufacture Esomeprazole Magnesium Delayed-Release Capsules OTC, 20 mg. Aurobindo Pharma Limited, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients.
10/19/17 - Getting a Handle on Prescription Medications
I'm concerned that my 80- year-old mother is taking too many medications. According to the Journal of the American Medical Association, around 40 percent of seniors, age 65 and older, take five or more medications. You should also note that October 21, is "National Check Your Meds Day.
10/18/17 - BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York
BioMarin Pharmaceutical Inc. updated the investment community on the Company's development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases. "In the near term, we are expecting an FDA decision on pegvaliase to treat adults with uncontrolled PKU in the first half of next year, and we continue to be rapidly
10/18/17 - Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced that it has received approval from Health Canada to market its best-selling, clinically.
10/18/17 - Janssen Announces U.S. FDA Approval of Stelara for the Treatment of Adolescents with Moderate to Sever Plaque Psoriasis
Release date- 13102017- Horsham, Pa.- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved an expanded indication for STELARA for the treatment of adolescents with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 'Psoriasis can affect many aspects of everyday life
10/18/17 - Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab
Release date- 17102017- TARRYTOWN, N.Y. and PARIS- Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderateto-severe eosinophilic esophagitis. The study showed that patients who received dupilumab weekly reported a significant improvement in the abil
10/17/17 - FDA Requests Nominations for Consumer Representatives on Advisory Committees
The Food and Drug Administration is requesting that any consumer organizations interested in participating in the selection of voting and/or nonvoting consumer representatives to serve on its advisory committees or panels notify FDA in writing, and that nominations for voting and/or nonvoting consumer representatives to serve on advisory...
10/17/17 - Innovus Pharmaceuticals Expands Its International Proprietary Product Patent Portfolio with Its First Chinese Patent
Release date- 16102017- Innovus Pharmaceuticals Inc., an emerging over the counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases,...
10/17/17 - JANSSEN ANNOUNCES U.S. FDA APPROVAL OF STELARA FOR THE TREATMENT OF ADOLESCENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Release date- 16102017- Horsham, Pa.- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved an expanded indication for STELARA for the treatment of adolescents with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 'Psoriasis can affect many aspects of everyday life
10/16/17 - Anthem, HealthCore and Boehringer Ingelheim Initiate World's Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting
By a News Reporter-Staff News Editor at Clinical Trials Week The first patients have now enrolled in AIRWISE, the world's largest ever pragmatic clinical trial in chronic obstructive pulmonary disease to study how commonly prescribed medicines may reduce the occurrence of exacerbations of COPD. This landmark research is a collaboration between An
10/16/17 - Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent alirocumab
By a News Reporter-Staff News Editor at Biotech Business Week Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen' s asserted patent claims for antibodies targeting PCSK9. This ruling means that Sano
10/16/17 - Eloxx Pharmaceuticals Announces Expansion of Intellectual Property Estate for ELX-02 with Newly Granted Patent in Europe
SAN DIEGO and TEL AVIV, Israel and BOSTON, Oct. 16, 2017/ PRNewswire/ Sevion Therapeutics, Inc. and Eloxx Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company developing novel small molecule medicines for genetic diseases caused by nonsense mutations, today announced that the European Patent Office has granted a patent covering the Co
10/16/17 - FDA clears first over-the-counter OTC carbon monoxide breath sensor for use in smoking cessation programs
By a News Reporter-Staff News Editor at Pharma Business Week Carrot Inc. announced that its Carbon Monoxide Breath Sensor System has been cleared by the U.S. Food and Drug Administration for over-the-counter commercial use in smoking cessation programs. "Smoking is the number one cause of preventable illness and death worldwide," 1 said David S.
10/16/17 - OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE in Japan
Release date- 13102017- MIAMI- OPKO Health, Inc. announced that its subsidiary EirGen Pharma has entered into an exclusive agreement with Japan Tobacco Inc. for the development and commercialization in Japan of RAYALDEE for the treatment of secondary hyperparathyroidism in non-dialysis and dialysis patients with chronic kidney disease.
10/16/17 - Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
TARRYTOWN, N.Y. and PARIS, Oct. 16, 2017/ PRNewswire/ Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from a Phase 2 investigational study of dupilumab in adults with active moderate-to-severe eosinophilic esophagitis. The study showed that patients who received dupilumab weekly reported a significant improvement in th
10/16/17 - Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis
Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis. Paris, France and Tarrytown, N.Y.- October 16, 2017- Sanofi and Regeneron Pharmaceuticals, Inc. today announced positive results from a Phase 2 investigational study of dupilumab in adults with active...
10/16/17 - Thinfilm and GlaxoSmithKline Bring NFC Technology to Leading Over-the-Counter Brand Flonase
By a News Reporter-Staff News Editor at Pharma Business Week Thin Film Electronics ASA, a global leader in NFC mobile marketing and smart packaging solutions, announced that GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies has commercially deployed Thinfilm's unique SpeedTap? tags to create...
10/15/17 - Savvy Senior: Getting a Handle on Prescription Medications
I'm concerned that my 80- year-old mother is taking too many medications. According to the Journal of the American Medical Association, around 40 percent of seniors, age 65 and older, take five or more medications. You should also note that October 21, is "National Check Your Meds Day.
10/13/17 - Janssen Announces U.S. FDA Approval Of STELARA (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration has approved an expanded indication for STELARA for the treatment of adolescents with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. "Psoriasis can affect many aspects of everyday life and the visible plaques, itchin
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415